Lilly CEO Is Optimistic on Cancer, Diabetes Drugs

July 24 (Bloomberg) -- John Lechleiter, chief executive officer of Eli Lilly & Co., talks with Bloomberg's Olivia Sterns about the company's second-quarter results, drugs and growth strategy. Lilly raised its full-year forecast after second-quarter sales grew faster than expected and cost-cutting programs took effect. (Source: Bloomberg)
Hacker Teen Uses 'Swatting' to Harass Online Gamers
53:07 - Bloomberg's Emily Chang reports on the teenage hacker who admitted to "swatting" online gamers. She speaks on "Bloomberg West." (Source: Bloomberg)
  • How Close Are We to an Uber IPO?
  • The Top Three Things to Watch for at Google I/O
  • U.S. Economy Set Up for Sept. or Oct. Rate Hike: Kleintop